Picomole’s Superb Trial Results
Moncton-based Picomole Inc., which is developing a breath analysis device that detects cancer, said yesterday its technology has produced preliminary accuracy of 98.5% in independent trials, which it believes makes it a world leader in detecting lung cancer.
The company has a working, portable prototype of its breathalyzer-like device that can detect lung cancer by identifying markers in breath samples and is spending 2013 performing clinical studies on the device and its infrared-based method of detecting cancer.
In a press release Wednesday, the company said it had conducted a pilot